Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alarcón, G S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alarcón, G S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 11, No. 2, 95-101 (2002)
DOI: 10.1191/0961203302lu155oa

Baseline characteristics of a multiethnic lupus cohort: PROFILE

G S Alarcón

Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; 615 MEB, The University of Alabama at Birmingham, Birmingham, AL 35294, USAgraciela.alarcon{at}ccc.uab.edu

G McGwin, Jr

Department of Surgery, Section of Trauma, Burns, and Critical Care, School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA

M Petri

Division of Rheumatology, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA

J D Reveille

Department of Medicine, Division of Rheumatology and Clinical Immunogenetics, School of Medicine, The University of Texas–Houston Health Science Center, Texas, USA

R Ramsey-Goldman

Division of Rheumatology, Northwestern University, School of Medicine, Evanston, IL, USA

R P Kimberly

the PROFILE Study Group

Purpose: To report the baseline characteristics of a US multi-ethnic, multi-regional, multi-institution cohort of patients with systemic lupus erythematosus (SLE) and how it was constituted. Methods: Patients with SLE per American college of Rheumatology (ACR) classification criteria, 16 years of age and older, with disease of 10 years or less, of Hispanic (H), African American (AA) or Caucasian (C) ethnicity and living in the geographic catchment areas of the participating institutions (the University of Alabama at Birmingham (UAB), Johns Hopkins University (JHU), The University of Texas-Houston Health Science Center (UTH) were eligible to enter the combined cohort (PROFILE, herein). Data from the individual SLE cohorts were pooled and the PROFILE cohort characteristics examined using descriptive statistics. Variables predictive of renal damage were then examined by logistic regression.

Results: The PROFILE cohort constituted by 568 patients (H = 78, AA = 216, C = 260 (13 other ethnicities)) is predominantly female. Non-C had a greater number of ACR criteria, and of renal involvement. Among the two non-C groups, a higher proportion of H patients have developed overall renal damage, as well as decreased glomerular filtration rate. Other than Hispanic ethnicity (odds ratio, OR = 6.27, confidence limits, CL = 1.96–220.01), sustained hypertension (OR = 14.16, CL = 4.52–4.43) was a significant predictor of renal damage, whereas belonging to the JHU cohort was protective (OR = 0.18, CL = 0.05–0.63).

Conclusions: We have constituted a large US multi-ethnic SLE cohort. Renal involvement was found to be more frequent among the non-C; within them, the H patients seem to be at higher risk for the occurrence of renal damage.

Key Words: lupus renal damage • Hispanic • African-American • ethnicity • cohort study


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
J. C. Edberg, J. Wu, C. D. Langefeld, E. E. Brown, M. C. Marion, G. McGwin Jr, M. Petri, R. Ramsey-Goldman, J. D. Reveille, S. G. Frank, et al.
Genetic variation in the CRP promoter: association with systemic lupus erythematosus
Hum. Mol. Genet., April 15, 2008; 17(8): 1147 - 1155.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R Ramsey-Goldman, G. Alarcon, G McGwin, M Petri, L. Vila, J. Edberg, J. Reveille, and R. Kimberly for the PR
Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort
Lupus, March 1, 2008; 17(3): 177 - 184.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
H. M. Bastian, G. S. Alarcon, J. M. Roseman, G. McGwin Jr, L. M. Vila, B. J. Fessler, J. D. Reveille, and for the LUMINA study group
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria
Rheumatology, April 1, 2007; 46(4): 683 - 689.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R T Naismith, K Trinkaus, and A H Cross
Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review
Multiple Sclerosis, November 1, 2006; 12(6): 775 - 781.
[Abstract] [PDF]


Home page
LupusHome page
G Contreras, V Pardo, C Cely, E Borja, A Hurtado, C De La Cuesta, K Iqbal, O Lenz, A Asif, N Nahar, et al.
Factors associated with poor outcomes in patients with lupus nephritis
Lupus, November 1, 2005; 14(11): 890 - 895.
[Abstract] [PDF]


Home page
LupusHome page
G Contreras, E Tozman, N. Nahar, and D. Metz
Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide
Lupus, March 1, 2005; 14(3_suppl): s33 - s38.
[Abstract] [PDF]


Home page
NEJMHome page
C.-S. Yee, C. Gordon, A. C. Gelber, L. Christopher-Stine, D. M. Fine, Y. Farhey, E. Hess, G. Contreras, O. Lenz, and D. Roth
Sequential Therapies for Proliferative Lupus Nephritis
N. Engl. J. Med., June 10, 2004; 350(24): 2518 - 2520.
[Full Text] [PDF]


Home page
NEJMHome page
G. Contreras, V. Pardo, B. Leclercq, O. Lenz, E. Tozman, P. O'Nan, and D. Roth
Sequential Therapies for Proliferative Lupus Nephritis
N. Engl. J. Med., March 4, 2004; 350(10): 971 - 980.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. S. Alarcon, J. M. Roseman, G. McGwin Jr, A. Uribe, H. M. Bastian, B. J. Fessler, B. A. Baethge, A. W. Friedman, and J. D. Reveille
Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage
Rheumatology, February 1, 2004; 43(2): 202 - 205.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M L Sanchez, G S Alarcon, G McGwin Jr, B J Fessler, and R P Kimberly
Can the weighted criteria improve our ability to capture a larger number of lupus patients into observational and interventional studies? A comparison with the American College of Rheumatology Criteria
Lupus, June 1, 2003; 12(6): 468 - 470.
[Abstract] [PDF]


Home page
LupusHome page
J Calvo-Alen, J D Reveille, V Rodriguez-Valverde, G McGwin Jr, B A Baethge, A W Friedman, and G S Alarcon
Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry
Lupus, May 1, 2003; 12(5): 377 - 385.
[Abstract] [PDF]